The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20

Eunmi Lee1, Maria Ouzounova1,2, Raziye Piranlioglu1

  • 1Department of Biochemistry and Molecular Biology, Georgia Cancer Center, Augusta University, Augusta, GA, 30912, USA.

Oncogene
|September 1, 2018
PubMed

Insights

Tumor necrosis factor-alpha (TNFα) drives triple-negative breast cancer (TNBC) aggressiveness via A20 upregulation. Conversely, A20 deficiency in luminal breast cancer leads to TNFα-induced cell death, revealing subtype-specific mechanisms.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor necrosis factor-alpha (TNFα) has dual roles in cancer, promoting growth or cell death.
  • The molecular mechanisms underlying TNFα's diverse effects in breast cancer subtypes are not fully understood.

Purpose of the Study:

  • To elucidate the role of TNFAIP3 (A20) in mediating TNFα's differential effects on triple-negative breast cancer (TNBC) and luminal (ER+) breast cancer subtypes.
  • To investigate how A20 influences breast cancer cell behavior, apoptosis, and metastasis.

Main Methods:

  • In vitro cell line assays.
  • Mouse xenograft models.
  • Analysis of TNFAIP3 (A20) expression and its downstream signaling pathways (HSP70, pStat3).

Main Results:

  • TNFα promotes aggressive properties in TNBC by upregulating A20.
  • TNFα induces cell death in luminal breast cancer cells that do not upregulate A20.
  • A20 overexpression protects luminal cells from TNFα-induced death, promotes EMT/CSC phenotypes, and enhances metastasis via MDSCs.

Conclusions:

  • A20 mediates the pleiotropic effects of TNFα, contributing to TNBC aggressiveness.
  • A20 deficiency leads to TNFα-induced apoptosis in luminal breast cancer, highlighting subtype-specific responses.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.8K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.0K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K